Dr. Michael Abramoff is the founder and executive chairman of IDX Technologies, the artificial intelligence diagnostic company that became the very first company in any field of medicine to get FDA approval for completely autonomous artificial intelligence. His remarkable instruments can independently analyze images of the retina for early signs of diabetic eye disease that thousands lose their vision to each year. This is the first in a three-part series on innovation in medicine and health. I'm your host, Senator Bill Frist.
Visit A Second Opinion's website here: https://asecondopinionpodcast.com/
Engage with us on social media at: Facebook Twitter Instagram
A Second Opinion with Senator Bill Frist, M.D.